Johnson & Johnson Booster Efficacy At 85% Found Effective Against COVID-19 Omicron Variant, South African Study Reveals

Medicine & Technology Jan 14, 2022

The head of South Africa's Medical Research Council or SAMRC, Glenda Gray recently claimed that the COVID-19 vaccine booster shot developed by Johnson and Johnson has 85-percent efficacy.

Dr. Fauci Suggests Skipping Mass New Year's Eve Celebrations Amid Continuing Increase of Omicron Cases in the US

Dec 30, 2021

Dr. Anthony Fauci has strongly recommended that people cancel plans of attending parties with 30 or more guests. Instead, he advised small gatherings of people or relatives "who are vaccinated" and are given a booster shot.

Moderna, Johnson & Johnsons to Offer Booster Shots; What Should We Know About These COVID-19 Vaccines?

Oct 20, 2021

An advisory to the US Food and Drug Administration unanimously voted last week, authorization of a booster jab, a third dose that is, of mRNA vaccine of Moderna, and second for Johnson & Johnson's.

Moderna COVID-19 Vaccine Makes Better Immune Response, Study Says

Sep 18, 2021

After clinical trial participants were completely vaccinated, the Moderna Covid-19 vaccine produced significant immunological and antibody responses for at least six months.

COVID-19 Vaccine: What’s the Difference Between FDA’s Full Approval and EUA of Pfizer, Other Inoculations?

Aug 24, 2021

There is a difference between full approval and emergency use authorization of the COVID-19 vaccine. They are granted by the US Food and Drug Administration to ensure safety and efficacy.

J&J Vaccine Works Well vs Delta Variant, Study Shows

Jul 02, 2021

Johnson & Johnson’s COVID-19 vaccine works well against the Delta variant that now dominates new infections in South Africa, country’s Medical Research Council said on Friday.

COVID-19 Vaccines: Moderna, Pfizer Effective Against New India Variant, Research Finds

May 12, 2021

A new study recently found that the two current COVID-19 vaccines from Moderna and Pfizer are effective against the new India variant.

COVID-19 Johnson & Johnson Vaccine: Blood Clots No Impact to Efficacy, Will Jabs Work for Mutant Variants?

Apr 29, 2021

Experts discuss the rare cases of blood clots linked to the COVID-19 Johnson & Johnson vaccine.

Pfizer Seeks FDA’s Approval for Younger Population’s Vaccination Aged 12 to 15 Year Olds

Apr 09, 2021

Pfizer has asked the FDA for an amendment to its emergency use authorization for its COVID-19 vaccine to expand its use in individuals aged 12 to 15 in the United States.

Pzifer vs. Moderna vs Johnson & Johnson COVID-19 Vaccines Efficacy, Distribution: What Should You Get?

Mar 01, 2021

The US is set to release its third vaccine against the novel coronavirus, but people cannot help ask which among the COVID-19 vaccines available are the best.

FDA Grants Emergency Use Authorization to Johnson & Johnson COVID-19 Vaccine

Feb 27, 2021

The FDA approved Johnson & Johnson’s COVID-19 vaccine for emergency use. The new vaccine is the first single-dose shot for coronavirus protection.

Is J&J’s COVID-19 Vaccine Safe and Effective? Here's What FDA Says

Feb 25, 2021

Johnson & Johnson's single-dose vaccine is 66.1% effective in reducing virus disease and shows evidence of stopping the transmission of the virus.

Johnson & Johnson COVID-19 Vaccine: How Effective Is It?

Feb 01, 2021

Johnson & Johnson's COVID-19 vaccine is effective with only a single dose, but questions swirl regarding decreased safety against one viral variant.

Johnson & Johnson COVID-19 Vaccine, Production Possibly Delayed

Jan 18, 2021

The Johnson & Johnson COVID-19 vaccine has been reported as safe and effective prevention of the virus.

Johnson & Johnson Vaccine Candidate To Begin Phase 3 of Human Trials

Sep 24, 2020

Johnson & Johnson will be entering phase three of human trials, including 60,000 participants from three continents. They also continue to look for other possible treatments for coronavirus as their vaccine candidate completes safety and efficacy trials.